no statement of use filed
on 19 Feb 2018
Last Applicant/ Owned by
2548 North Holton Street
Milwaukee
US
WI
53212
Serial Number
87083307 filed on 24th Jun 2016
Registration Number
N/A
Correspondent Address
EDUARDO DRAKE
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement fRead More
Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement for treating symptoms of Crohns disease, multiple sclerosis, insomnia; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Anti-epileptic pharmaceutical preparations; Dietary and nutritional supplements containing cannabis derivatives, namely, cannabidiol (CBD) oil; Dietary supplements also containing cannabis derivatives, namely, cannabidiol (CBD) oil; Digestives for pharmaceutical purposes; Medicated skin care preparations; Medicated oils containing cannabis derivatives, namely, cannabidiol (CBD) oil; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis, namely, cannabidiol (CBD) oil; Therapeutic pharmaceutical for the treatment of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Therapeutic pharmaceutical for the treatment of inflammation, nausea, convulsions, cancer, anxiety, depression; Therapeutic pharmaceutical for the treatment of Crohns disease, multiple sclerosis, and insomnia
No 87083307
No Service/Collective Mark
No 207.002TM1
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 20th Feb 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 19th Feb 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| 18th Jul 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 23rd May 2017 | PUBLISHED FOR OPPOSITION |
| 23rd May 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 03rd May 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 14th Apr 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th Apr 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 07th Apr 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 07th Apr 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
